Sign in

Global Nexus

@mcmasternexus.bsky.social
59 followers 22 following 4 posts

A McMaster-based health innovation accelerator. Home of the new inhaled vaccine and other cutting-edge health solutions.

PostsRepliesMedia
Global Nexus @mcmasternexus.bsky.social · 09/07/2025
Global Nexus Director Matthew Miller has been named University Scholar — an honour recognizing international research excellence, mentorship, and community impact. Congratulations to Dr. Miller and the other outstanding recipients! 👏 brighterworld.mcmaster.ca/articles/uni...
brighterworld.mcmaster.ca
Eight remarkable professors named University Scholars
Eight McMaster professors have been named 2025 University Scholars, in recognition of their research leadership and the impact of their work. University Scholars are mid-career . . .
010
Global Nexus @mcmasternexus.bsky.social · 08/07/2025
🦠 Clinical Trial Update 🦠 McMaster University's inhaled COVID-19 #vaccine safely generates immune responses associated with protection in the lungs, according to phase-1 clinical trial data published in Nature Communications. Our inhaled vaccine is now in ongoing phase-2 trials. Learn more 👇
healthsci.mcmaster.ca
021
Global Nexus @mcmasternexus.bsky.social · 11/03/2025
Today, on the five-year anniversary of the WHO's pandemic declaration, we're proud to commence Phase-II human trials on our inhaled aerosol vaccine. Learn more about this exciting next-gen vaccine candidate, including how to enrol in the ongoing study. 👇 healthsci.mcmaster.ca/made-at-mcma...
041
Reposted by Global Nexus
Michael G. DeGroote Institute for Infectious Disease Research @mcmasteriidr.bsky.social · 04/12/2024
New from @macleans.bsky.social: How IIDR member Jon Stokes is working at the intersect of academia and industry to get new antibiotics to the finish line faster. #IDSky macleans.ca/society/heal...
macleans.ca
How an Ontario Startup Is Fighting Superbugs With AI - Macleans.ca
Antibiotic-resistant bacteria are overpowering existing treatments. One Hamilton-based lab is using medical AI to fight back.
132
Global Nexus @mcmasternexus.bsky.social · 28/11/2024
The Government of Canada announced today a $4M investment in Global Nexus, which will be leveraged for bold new drug discovery and development initiatives at McMaster. brighterworld.mcmaster.ca/articles/fed...
brighterworld.mcmaster.ca
Government of Canada invests $4M in McMaster to fast-track drug discovery initiatives
The funding will support the establishment of a research centre that will significantly expand the university’s capacity for research, partnerships and training to drive new therapies to market.
042
Reposted by Global Nexus
Dr. Dawn Bowdish @msmacrophage.bsky.social · 21/11/2024
Hey #IDSky, #Microsky and #ImmunoSky - I'm so pleased that @mcmasteriidr.bsky.social and @mcmasternexus.bsky.social are now here, as well as microbiologists extraordinaire @gdwantibiotics.bsky.social @dr-lori-burrows.bsky.social and @lkalan.bsky.social - get these folks in some #starterpacks!
0184
Reposted by Global Nexus
Michael G. DeGroote Institute for Infectious Disease Research @mcmasteriidr.bsky.social · 21/11/2024
Putting the 'ant' in antibiotic discovery: how IIDR researchers are harnessing an eons-old relationship between ants, fungi, and bacteria to find new antimicrobial medicines. #AMR #WorldAMRAwarenessWeek www.youtube.com/watch?v=jpt9...
youtube.com
Ants and antibiotics: How insects could help beat drug-resistant superbugs
YouTube video by McMaster University
0113